Insights from a double-blind, randomized, direct-to-participant intervention trial for Long COVID
BACKGROUND
Long COVID affects an estimated 400 million people worldwide, and is associated with low quality of life. Nearly all completed Long COVID clinical trials reported no benefit, and most...
Exploring the effects of GLP-1 receptor agonists in fibromyalgia: a propensity-matched real-world cohort using TriNetX research platform
Nouran Eshak, Anushka Irani, Megan Sullivan
[Line breaks added]
Objectives
We aimed to evaluate the effects of GLP-1 receptor agonists (GLP-1RA) on symptom...
Now published, see post #4
--------
Urinary Peptidomic Profiling in Post-Acute Sequelae of SARS-CoV-2 Infection: A Case-Control Study
Dilara Guelmez, Justyna Siwy, Katharina Kurz, Ralph Wendt, Miroslaw Banasik, Bjorn Peters, Emmanuel Dudoignon, Francois Depret, Mercede Salgueira, Elena...
Effectiveness and tolerability of liraglutide as add-on treatment in patients with obesity and high-frequency or chronic migraine: A prospective pilot study
Simone Braca, Cinzia Valeria Russo, Antonio Stornaiuolo, Gennaro Cretella, Angelo Miele, Caterina Giannini, Roberto De Simone
[Line...
Article: Why Does Ozempic Cure All Diseases?
https://www.astralcodexten.com/p/why-does-ozempic-cure-all-diseases?utm_campaign=post&triedRedirect=true
I believe that @leokitten has had some relief from MECFS at higher doses of Zepbound.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.